Canary Speech utilizes AI-driven vocal digital biomarkers to analyze acoustic and linguistic features from conversational speech, providing rapid assessments of cognitive and behavioral conditions. This technology enables early detection of health issues, reducing hospital readmissions and preventing unnecessary hospitalizations.
Funding
$23.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

CCFounders
Product
Problem
The healthcare system faces challenges in early detection and monitoring of cognitive and behavioral conditions due to reliance on traditional clinical screenings that are often time-consuming, resource-intensive, and may not identify subtle early indicators. Delayed diagnosis can lead to increased hospital readmissions, preventable hospitalizations, and higher overall healthcare costs.
Solution
Canary Speech offers an AI-powered vocal biomarker technology that analyzes acoustic and linguistic features extracted from brief conversational speech to provide rapid, objective assessments of cognitive and behavioral health. This technology enables earlier detection of conditions compared to traditional methods, allowing clinicians, payers, and patients to proactively address health issues. By identifying subtle vocal indicators, Canary Speech aims to reduce hospital readmissions, prevent unnecessary hospitalizations, and improve patient outcomes through timely intervention. The analysis is performed within seconds, providing clinicians with actionable insights to inform treatment decisions.
Target Audience
The primary target audience includes clinicians, healthcare providers, payers, and patients seeking early and objective assessments of cognitive and behavioral health conditions.
Features
- Patented vocal biomarker technology analyzing acoustic and linguistic features from conversational speech.
- AI-driven analysis providing objective assessments of cognitive and behavioral conditions.
- Rapid results delivered within seconds of speech analysis.
- Early detection capabilities, identifying conditions before observable symptoms.